| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Rheumatoid arthritis | 165 | 86 | |
| Psoriatic arthritis | 39 | 25 | |
| Psoriasis | 20 | 7 | |
| Ankylosing spondylitis | 12 | 6 | |
| Systemic lupus erythematosus | 6 | 3 |
Common side effects
| Side effect | Patients | Percentage |
|---|---|---|
| Fatigue | 6 | |
| Injection site redness | 4 | |
| Bruising | 3 | |
| Headaches | 3 | |
| Injection site itching | 3 | |
| Injection site bruising | 2 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 9 | |
| Moderate | 20 | |
| Mild | 33 | |
| None | 61 |
Member evaluations
kitrona
evaluated on Apr 16, 2009
- Perceived effectiveness for inflammation in joints: Moderate
- Side effects: Moderate
llamaem
evaluated on Jun 30, 2010
- Perceived effectiveness for rheumatoid arthritis: Moderate
- Side effects: Moderate
frantasm
evaluated on Jul 10, 2012
- Perceived effectiveness for rheumatoid arthritis: Moderate
- Side effects: Mild